SNPS in the HIV-1 tata box and the aids pandemic

Journal of Bioinformatics and Computational Biology

Volumn 8, Issue 3, 2010, Pages 607-625

  Suslov, Valentin V ^a   Ponomarenko, Petr M ^a,b   Efimov, Vadim M ^a   Savinkova, Ludmila K ^a   Ponomarenko, Mikhail P ^a   Kolchanov, Nikolay A ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

HIV 1; Prediction; SNP; TATA binding protein (TBP); TATA box; TBP TATA affinity

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; EPIDEMIC; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNATIONAL COOPERATION; METHODOLOGY; NUCLEOTIDE SEQUENCE; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS; TATA BOX; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE OUTBREAKS; DNA MUTATIONAL ANALYSIS; HIV-1; HUMANS; INTERNATIONALITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; TATA BOX;

EID: 77953679484     PISSN: 02197200     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0219720010004677     Document Type: Conference Paper

References (60)

1. Gupta RM, Sahni AK, Jena J, Nema SK, Genomic diversity of human immunodeficiency viruses, MJAFI 61:267-270, 2005.
2. Peeters M, Chaix M-L, Delaporte E, Phyloǵenie des SIV et des VIH, Medecine/Sciences 24:621-628, 2008 (in French).
3. Holmes ES, When HIV spread afar, Proc Natl Acad Sci USA, 104:18351-18352, 2007.
4. In vivo Models of HIV Disease and Control, Friedman H, Specter S, Bendinelli M (eds), Springer Science+Business Media, New York, 2006.
5. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM, The Challenge of HIV-1 Subtype Diversity, N Engl J Med 358:1590-1602, 2008.
6. Keele BF, Van Heuverswyn F, Li Y et al., Chimpanzee reservoirs of pandemic and nonpandemic HIV-1, Science 313:523-526, 2006.
7. Korber B, Muldoon M, Theiler J et al., Timing the ancestor of the HIV-1 pandemic strains, Science 288:1789-1796, 2000.
8. Gilbert MT, Rambaut A, Wlasiuk G et al., The emergence of HIV/AIDS in the Americas and beyond, Proc Natl Acad Sci USA 104:18566-18570, 2007.
9. Requejo HI, Worldwide molecular epidemiology of HIV, Rev Saude Publica 40: 331-345, 2006.
10. McCutchan FE, Global epidemiology of HIV, J Med Virol 78:S7-S12, 2006.
11. Hemelaara J, Gouws E, Ghys PD, Osmanov S, Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004, AIDS 20:W13-W23, 2006.
12. Supotnitskiy VV, Micro-Organisms, Toxins, and Epidemics. Vusovskaya. Kniga, Moscow, Russia, 2005 (in Russian).
13. Kalish ML, Robbins KE, Pieniazek D et al., Recombinant viruses and early global HIV-1 epidemic, Emerg Infect Dis 10:1227-1234, 2004.
14. Olsen HS, Rosen CA, Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression, J Virol 66:5594-5597, 1992.
15. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ, Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity, J Virol 70:4053-4062, 1996.
16. Nabel G, Baltimore D, An inducible transcription factor activates expression of human immunodeficiency virus in T cells, Nature 326:711-717, 1987.
17. Zhang L, Huang Y, Yuan H, Chen BK, Ip J, Ho DD, Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection, J Virol 71:5608-5613, 1997. (Pubitemid 27258240)
18. Ou SH, Garcia-Martínez LF, Paulssen EJ, Gaynor RB, Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function, J Virol 68: 7188-7199, 1994.
19. Brady J, Kashanchi F, Tat gets the "green" light on transcription initiation, Retrovirology 2:69, 2005.
20. Raha T, Cheng SW, Green MR, HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs, PLoS Biol 3(2):e44, 2005.
21. Majello B, Napolitano G, Lania L, Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation, AIDS 12(15):1957-1964, 1998.
22. Hoey T, Weinzierl RO, Gill G, et al., Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators, Cell 72:247-260, 1993.
23. Gill G, Pascal E, Tseng ZH, Tjian R, A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation, Proc Natl Acad Sci USA 91:192-196, 1994.
24. Deng L, Ammosova T, Pumfery A, Kashanchi F, Nekhai S, HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter, J Biol Chem 277:33922-33929, 2002.
25. Lusic M, Marcello A, Cereseto A, Giacca M, Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter, EMBO J 22: 6550-6561, 2003.
26. JPawlowski J, Montoya-Burgos JI, Fahrni JF, Wüest J, Zaninetti L, Origin of the Mesozoa inferred from 18S rRNA gene sequences, Mol Biol Evol 13:1128-1132, 1996.
27. Ponomarenko PM, Savinkova LK, Drachkova IA, Lysova MV, Arshinova TV, Ponomarenko MP, Kolchanov NA, A step-by-step model of TBP/TATA box binding allows predicting human hereditary diseases by single nucleotide polymorphism, Dokl Biochem Biophys 419:88-92, 2008.
28. Darling AC, Mau B, Blattner F, Perna NT, Mauve: multiple alignment of conserved genomic sequence with rearrangements, Genome Res 14:1394-1403, 2004.
29. Montano MA, Nixon CP, Essex M, Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter, J Virol 72:8446-8452, 1998.
30. Savinkova LK, Drachkova IA, Ponomarenko MP, Lysova MV, Arshinova TV, Kolchanov NA, Interaction between the recombinant TATA-binding protein and the TATA-boxes of the mammalian gene promoters, Ecological Genetics V:44-49, 2007 (in Russian).
31. Ponomarenko MP, Ponomarenko JV, Frolov AS, Podkolodny NL, Savinkova LK, Kolchanov NA, Overton GC, Identification of sequence-dependent features correlating to activity of DNA sites interacting with proteins, Bioinformatics 15:687-703, 1999.
32. Hahn S, Buratowski S, Sharp PA, Guarente L, Yeast TATA-binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences, Proc Natl Acad Sci USA 86:5718-5722, 1989.
33. Coleman RA, Pugh BF, Evidence for functional binding and stable sliding of the TATA binding protein on nonspecific DNA, J Biol Chem 270:13850-13859, 1995.
34. Bucher P, Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences, J Mol Biol 212:563-578, 1990.
35. Juo ZS, Chiu TK, Leiberman PM, Baikalov I, Berk AJ, Dickerson RE, How proteins recognize the TATA box, J Mol Biol 261:239-254, 1996.
36. Powell R, Parkhurst K, Parkhurst L, Comparison of TATA-binding protein recognition of a variant and consensus DNA promoters, J Biol Chem 277:7776-7784, 2002.
37. Ponomarenko MP, Savinkova LK, Ponomarenko JV, Kel AE, Titov II, Kolchanov NA, Modeling TATA-box sequences in eukaryotic genes,Mol Biol (Mosk) 31:726-732, 1997 (in Russian).
38. IUPAC-IUB commission on biochemical nomenclature (CBN), J Mol Biol 55: 299-310, 1971.
39. Karas H, Knüppel R, Schulz W, Sklenar H, Wingender E, Combining structural analysis of DNA with search routines for the detection of transcription regulatory elements, Comput Appl Biosci 12(5):441-446, 1996.
40. Delgadillo RF,Whittington JE, Parkhurst LK, Parkhurst LJ, The TATA-binding protein core domain in solution variably bends TATA sequences via a three-step binding mechanism, Biochemistry 48:1801-1809, 2009.
41. Ponomarenko PM, Ponomarenko MP, Drachkova IA, Lysova MV, Arshinova TV, Savinkova LK, Kolchanov NA, Prognosis of affinity change of the TATA-binding protein to TATA-boxes upon polymorphisms of the human gene promoter TATA boxes, Mol Biol (Mosk) 43(3):512-520, 2009 (in Russian).
42. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL, Kolchanov NA, Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL, Nucleic Acids Res 26(1):362-367, 1998.
43. Imai K, Okamoto T, Transcriptional repression of human immunodeficiency virus type 1 by AP-4, J Biol Chem 281:12495-12505, 2006. (Pubitemid 43855336)
44. Struhl K, The yeast his3 promoter contains at least two distinct elements, Proc Natl Acad Sci USA 79:7385-7389 (1982).
45. Bouŕee P, Lamour P, Bisaro F, Didier E, Etude d'une population d'origine tropicale, VIH positive, dans un centre de ŕefugíes en France, Bull Soc Pathol Exot 88:24-28, 1995 (in French).
46. Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J, The spread, treatment, and prevention of HIV-1: evolution of a global pandemic, J Clin Invest 118:1244-1254, 2008.
47. Lau KA, Wang B, Saksena NK, Emerging trends of HIV epidemiology in Asia, AIDS Rev 9:218-229, 2007.
48. King MC, Wilson AC, Evolution in two levels in humans and chimpanzees, Science 188:107-116, 1975.
49. Carroll SB, Evolution at Two Levels: On Genes and Form, PLoS Biol 3:e245, 2005.
50. Roques P, Robertson DL, Souquìere S et al., Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure, Virology 302:259-273, 2002.
51. Coutinho RA, Some aspects of the natural history of HIV infection, Trop Med Int Health 5:A22-25, 2000.
52. Herbeck JT, Nickle DC, Learn GH et al., Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host, J Virol 80: 1637-1644, 2006.
53. Maljkovic Berry I, Ribeiro R, Kothari M et al., Unequal evolutionary rates in the human immunodeficiency virus type 1 (HIV-1) pandemic: the evolutionary rate of HIV-1 slows down when the epidemic rate increases, J Virol 81:10625-11035, 2007.
54. Couturier E, Damond F, Roques P et al., HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network, Bull Soc Pathol Exot 88:24-28, 1995.
55. Arïen KK, Troyer RM, Gali Y, Colebunders RL, Arts EJ, Vanham G, Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time, AIDS 19:1555-1564, 2005.
56. Arïen KK, Vanham G, Arts EJ, Is HIV-1 evolving to a less virulent form in humans?, Nat Rev Microbiol 5:141-151, 2007.
57. Quiñones-Mateu ME, Is HIV-1 evolving to a less virulent (pathogenic) virus?, AIDS 19:1689-1690, 2005.
58. Du Guerney J, Migrations et SIDA en Afrique, Chron CEPED Autumn (15):4-5, 1994 (in French).
59. Amat-Roze JM, Coulaud JP, Charmot G, La ǵeographie de l'infection par les virus de l'immunod́eficience humaine (VIH) en Afrique Noire: mise en ́evidence de facteurs d'́epid́emisation et de ŕegionalisation, Bull Soc Pathol Exot 83:137-148, 1990 (in French).
60. Vallet S, Legrand-Quillien MC, Roger C et al., HIV-1 genetic diversity in Western Brittany, France, FEMS Immunol Med Microbiol 34:65-71, 2002.